Logos Global Management as of March 31, 2025
Portfolio Holdings for Logos Global Management
Logos Global Management holds 39 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ideaya Biosciences (IDYA) | 10.2 | $57M | 3.5M | 16.38 | |
| Revolution Medicines (RVMD) | 10.1 | $57M | 1.6M | 35.36 | |
| Akero Therapeutics (AKRO) | 8.6 | $49M | 1.2M | 40.48 | |
| Janux Therapeutics (JANX) | 7.9 | $45M | 1.7M | 27.00 | |
| Nuvalent Inc-a (NUVL) | 6.3 | $36M | 500k | 70.92 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.6 | $26M | 1.7M | 15.37 | |
| Xenon Pharmaceuticals (XENE) | 3.9 | $22M | 650k | 33.55 | |
| Keros Therapeutics (KROS) | 3.6 | $20M | 2.0M | 10.19 | |
| Disc Medicine (IRON) | 3.5 | $20M | 394k | 49.64 | |
| Biontech Se Sponsored Ads (BNTX) | 3.2 | $18M | 200k | 91.06 | |
| 89bio (ETNB) | 3.2 | $18M | 2.5M | 7.27 | |
| Soleno Therapeutics (SLNO) | 3.2 | $18M | 250k | 71.45 | |
| Erasca (ERAS) | 3.2 | $18M | 13M | 1.37 | |
| Ocular Therapeutix (OCUL) | 3.0 | $17M | 2.3M | 7.33 | |
| Design Therapeutics (DSGN) | 2.9 | $16M | 4.2M | 3.86 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.4 | $14M | 350k | 39.07 | |
| Geron Corporation (GERN) | 2.3 | $13M | 8.0M | 1.59 | |
| Olema Pharmaceuticals (OLMA) | 2.1 | $12M | 3.2M | 3.76 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.1 | $12M | 350k | 33.54 | |
| Avidity Biosciences Ord (RNA) | 1.8 | $10M | 350k | 29.52 | |
| Maze Therapeatics (MAZE) | 1.8 | $10M | 937k | 11.01 | |
| Annexon (ANNX) | 1.4 | $7.7M | 4.0M | 1.93 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.3 | $7.4M | 425k | 17.31 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.0 | $5.7M | 2.0M | 2.86 | |
| Dyne Therapeutics (DYN) | 0.9 | $5.2M | 500k | 10.46 | |
| Enliven Therapeutics (ELVN) | 0.8 | $4.7M | 240k | 19.68 | |
| Immunovant (IMVT) | 0.8 | $4.7M | 275k | 17.09 | |
| Aerovate Therapeutics (AVTE) | 0.6 | $3.5M | 1.4M | 2.51 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $3.4M | 2.2M | 1.53 | |
| Unicycive Therapeutics | 0.5 | $2.9M | 5.1M | 0.57 | |
| Trevi Therapeutics (TRVI) | 0.5 | $2.7M | 425k | 6.29 | |
| Astria Therapeutics | 0.5 | $2.7M | 500k | 5.34 | |
| Rapport Therapeutics (RAPP) | 0.4 | $2.1M | 209k | 10.03 | |
| Glycomimetics | 0.2 | $1.1M | 5.4M | 0.21 | |
| Septerna (SEPN) | 0.1 | $777k | 134k | 5.79 | |
| Allakos | 0.1 | $660k | 2.9M | 0.23 | |
| Artiva Biotherapeutics (ARTV) | 0.1 | $435k | 145k | 3.00 | |
| Solid Biosciences Com New (SLDB) | 0.1 | $370k | 100k | 3.70 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $16k | 67k | 0.24 |
